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Background: The advent of percutaneous intervention has made surgical treatment of
coronary artery disease less favored by patients though the evidence that supports CABG in
certain patient subsets is strong.
Methods: Literature review was done using Pubmed, Scopus, Google and Google Scholar
with MeSH terms-coronary artery bypass grafting, internal mammary artery, drug eluting
stent, stroke, myocardial revascularization.
Results: The adoption of evolving techniques like anaortic off pump grafting, bilateral in-
ternal mammary artery use, hybrid and minimally invasive coronary revascularization
techniques, intra-operative graft assessment, and heart team approach can lead to better
outcomes following surgery as is evidenced by recent literature.
Conclusions: Though the adoptability of the newer strategies may vary between centers a
close coalition between coronary surgeons and cardiologists would ensure that the man-
agement of coronary artery disease is based on evidence for the benefit of the patient.
Copyright © 2015, Cardiological Society of India. All rights reserved.1. Introduction
Coronary artery disease (CAD) is predicted to be the cause for
14.2% deaths by 2030.1 The advances made in the percuta-
neous treatment of CAD and the advent of various generations
of stents has broadened the indications of PCI in recent times.
However there is overwhelming evidence in the literature
comparing CABG with medical therapy and variations of PCI
in specific patient subsets showing the superiority of CABG in
terms of the long term survival benefits and repeat revascu-
larization rates.2,3 The inherent invasiveness of conventionaliovascular and Thoracic
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ociety of India. All rightsCABG with the attendant risks of peri-operative stroke and
morbidity have proved decisive in the decline of its popularity
in the present era of absorbable stents.
Evolving surgical strategies likely aortic no touch tech-
nique/total arterial coronary revascularization [TACR], bilat-
eral internal mammary artery (BIMA) use, multiple arterial
grafting (MAG), minimally invasive CABG, hybrid coronary
revascularization (HCR) techniques and intra-operative graft
assessments have to routinely become part of coronary sur-
geon's armamentarium to stay competitive and take the
practice to the next level. At the same time, the emphasis on
close coalition with the core team of cardiologists with inputSurgery, Rajagiri Hospital, Chunangamvely, Aluva, Kochi 683112,
reserved.
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with the patient and the patient himself/herself should guide
the decision making process. Hence the approach to treating
CADwith a “Heart Team (HT)” concept seems to be the need of
the hour. This review discusses the evidence based, adoptable
strategies for the coronary surgeon to remain competitive yet
co-operative and potentially alter the way CAD is treated for
better patient outcomes.2. Bilateral internal mammary artery (BIMA)
use
Although the use of single internal mammary artery (SIMA)
has become part of a standard practice protocol in CABG, the
routine use of BIMA has found a patronage of only 4e12% as
per the statistics based on Society of Thoracic Surgeons
Database.4 There are consistent reports in the literature
quoting the superiority of BIMA over SIMA grafting. The
advantage of two arterial grafts supplying vital areas of
myocardium afford better protection from long term adverse
events especially considering the inferior patency rates of
saphenous venous grafts (SVG) for the same territories. Weiss
et al in a recent meta-analysis have documented that the long
term survival of BIMA group was significantly higher than
SIMA group.5
As observed by Lytle et al in a previous landmark study, the
incremental benefit of using BIMA for the first 12 years in the
younger subset of patients would be in its value in the pre-
vention of repeat revascularizations and the real survival
benefit of BIMA vs SIMA use would be apparent beyond this
time-frame.6 In a follow up study by the same author, it was
noted that the general survival benefit associated with BIMA
grafting extended for twenty post-operative years. As ex-
pected from the pilot study the increasing advantage of a
BIMA graft became apparent only in the second decade after
surgery.7
Concerns about deep sternal wound infections [DSWI]
have limited BIMA use by surgeons. The reported incidence of
DSWI with BIMA use vary from 0.3% to as high as 16% in
different series. The risk factors associated with DSWI are
female sex, obesity, and diabetes.8 The use of skeletonized
harvest technique for BIMA with the proposed advantage of
the preservation of sternal blood supply has clearly shown
reduction in the incidence of DSWI by some groups.9 However
the same reduction in the incidence of DSWI could not be
replicated with a pedicled BIMA harvest technique.
Thus though the retrospective and other observational
studies have registered a long term survival benefit for BIMA
grafting, a randomized prospective trial to validate this is the
need of the hour. The ART trial was designed to this end.
The ART, a multi-centric prospective trial comparing the
long-term survival benefits of BIMA versus SIMA grafting is
now underway involving 3102 patients either assigned to
BIMA or SIMA arms. As expected the short term outcomes of
BIMA and SIMA grafting with respect tomortality appear to be
comparable in this trial. In concordance with the previous
studies BIMA and SIMA groups were comparable in the other
short term outcomes like, major complications, myocardial
infarctions, stroke, and repeat revascularization rates.However there was an increased incidence of DSWI and
sternal wound reconstructions in BIMA group [1.9% (BIMA) vs
0.6% (SIMA)].10
The long term results of ART is expected to resolve the
ongoing debate on the choice of BIMA vs SIMA and the
attendant risks.3. Stroke prevention and no touch technique
One of themajor limitations of CABG is the higher incidence of
stroke peri-operatively and during early follow up when
compared to PCI in similar patient subsets. Peri-operative
stroke hikes the risk for peri-operative mortality, extends the
hospital stay and adds to the economic burden. In SYNTAX
trial the higher incidence of peri-operative stroke was found
to even out with the PCI group at the end of 2 years. By the end
of 5 years, the incidence of stroke in PCI group was 2.4% as
against 3.7% in the CABG group which was not statistically
significant. In the early SYNTAX follow up data the incidence
of stroke was higher in the CABG group especially in patients
with a higher SYNTAX score. This difference evened out at
mid-term follow up.2 Despite the fact that most of the peri-
operative strokes documented in the SYNTAX trial occurred in
the waiting period for surgery and might have contributed to
the higher early stroke rates in the CABG cohort, another well
planned randomized trial (FREEDOM)3 also drew similar con-
clusions on this, with a higher stroke rate in the peri-operative
period. At 5 years, while the CABG group was still trending
towards a higher incidence of stroke (5.4% as against 2.4% in
the PCI group). This trial was done on patients with multi-
vessel disease (increased disease burden) and diabetes melli-
tus [DM] (independent risk factor for stroke) and returned
similar results as in SYNTAX. The results with regard to the
incidence of stroke after CABG were similar in the ASCERT
study also with a higher early stroke rate in the CABG arm and
a decreasing incidence of the complication with longer dura-
tion of follow up.11 These studies thus expose the disadvan-
tage of CABG in the incidence of early and peri-operative
period.
Etiology of peri-operative stroke after CABG is multifacto-
rial. Embolism and the water shed infarcts resulting from the
low perfusion pressures are implicated frequently. Roach et al
in a large multicenter study had classified the neurological
outcomes after elective coronary artery bypass and found that
the Type 1 group which included the peri-operative stroke
subsets to be strongly associated with ascending aortic
atherosclerosis.12 A prospective study spanning 30 years
involving various modalities of surgical revascularization re-
ported the risk of intra-operative stroke to be higher with
increasing atherosclerotic disease burden.13
The avoidance of aortic manipulation has been thus pro-
posed to decrease the incidence of peri-operative stroke.
Although off pump CABG (OPCAB) has been found to have
lower incidence of stroke rate when compared to the con-
ventional CABG, its utilitymay be limited if partial clamping of
aorta is practiced. Wolf et al had studied the incidence of solid
micro-emboli by transcranial Doppler in patients undergoing
CABG with or without aortic clamping. The reduction in the
number of solidmicro-emboli was significant in the clampless
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technique to minimize the peri-operative neurological
events.14
Borgermann et al compared clampless OPCAB (anaortic/
aortic no touch OPCAB) with conventional CABG by a pro-
pensity matched analysis and reported lower incidence of
stroke and mortality with the clampless off pump tech-
nique.15 In a subgroup analysis of SYNTAX trial the incidence
of stroke in the conventional CABG arm at 3 years follow up
was compared with that of anaortic OPCAB arm. The per-
centage of stroke was trending towards a lower but non-
significant value with the aortic no touch technique (1.3% in
the no touch group vs 3.4% in the SYNTAX group). Moreover,
the no-touch group results compared favorably with the
stroke percentage in the PCI armof SYNTAX trial, thusmaking
the technique as safe as PCI with respect to the post-operative
stroke rate. (1.3% (no-touch) vs 2%(PCI arm).16
Incidence of peri-operative strokes in anaortic OPCAB vs
conventional CABG was studied by Misfeld et al. This was one
of the largest studies comparing the aortic no touch technique
with the conventional CABG. The investigators performed
either anaortic no touch total arterial coronary revasculari-
zation (TACR) (using in situ arterial grafts) or clampless
proximal anastomosis for SVG to the ascending aorta with the
Heart String (HS) device in the anaortic OPCAB group. The
stroke rates were significantly lower for the TACR/HS OPCAB
group when compared to the conventional CABG group.17
On the other hand Emmert et al reported that the incidence
of peri-operative stroke remained the same regardless of off-
pump or on pump grafting techniques if partial aortic
clamping was practiced. The stroke rate associated with the
HS device in this study was lower than that of conventional
CABG (0.7% vs 2.3%). Also, stroke rates achieved by utilizing
either HS or no touch TACR were reported to be similar in the
study.18
Thus, it may be safely inferenced that in patients with
higher risk of post-operative neurological complications the
technique of anaortic OPCAB utilizing TACR or the proximal
anastomotic systems should be the practice recommendation
for surgical coronary revascularization. This could normalize
the gap between the CABG and PCI in terms of both in-hospital
and early post-operative stroke rates.
3.1. Multiple arterial grafting (MAG)
SVG are the most common conduits used for CABG. Available
literature reports their poorpatency rateof 50%at10year follow
up and about three quarters get occluded at 15 years.19 The
inferior patency rates of SVG harvested via the conventional
techniques have prompted the surgeons to look for alternate
arterial conduits with better patency rates. As already stated
BIMA grafting has demonstrated superiority over SIMA in
angina relief and a survival benefit.5 In recent times, the addi-
tion of a third ormultiple arterial grafts to the BIMAhas become
a routine practice in many centres performing CABG. A
considerable amount of evidence has been generated off late
reporting better long term outcomes in patients receiving
multiple arterial grafts. Technique wise the left coronary (for
utilization of arterial grafts) is given priority over the right sys-
tem unless the right coronary vessels are tightly stenosed toprevent competitive flow related occlusion or stringing. Use of
both the internalmammary arteries on to the left system (BIMA
grafting) would require a third arterial graft onto the right sys-
tem if TACR is planned. The most common conduits used for
the right system are right internal mammary artery (RIMA),
radial artery (RA) and right gastroepiploic artery (RGEA).20,21
3.1.1. Right internal mammary artery (RIMA)
RIMA use has been widespread and current evidence suggests
that it works best when anastomosed onto the left coronary
system-LAD and its branches or the circumflex system.
Although the reported patency of RIMA is comparable to LIMA
when used for grafting LAD,22 the same results could not be
replicated when used as a conduit for the right system. Pre-
vious evidence has shown that grafting RIMA onto the right
coronary system returned inferior patency rates as compared
to grafting onto the left system and was prone to stringing if
the stenosis was <90%.23
This could have been due to the deployment of the
conduit onto the distal right coronary where it is easier to
graft the vessel with an in situ RIMA for want of length. The
high propensity of the development of the right coronary
crux disease as it is a branching point24 and the competitive
flow pattern could have resulted in the inferior patency rates.
Hence it is wiser to use RIMA on the left side of the heart and
preferably distally onto the PDA when used on the right
coronary system to decrease the possibility of graft failure.
On the left side of heart, in situ RIMA can easily reach a
ramus intermedius or the high obtuse marginals. It can be
positioned behind the thymus and anterior to aorta to reach
this position. To afford more length it can be tunneled behind
the ascending aorta with the obvious risks of rotation and
non-accessibility in case of bleeding. RIMA is best used as a
free graft if mid and distal territories are being grafted for
want of adequate length.25
3.1.2. Radial artery (RA)
RA was first used for CABG by Carpentier et al as early as in
1974,26 but later was abandoned due to adverse results
attributed to narrowing and spasm. The interest in RA usewas
revived by Acar et al in the nineties.27
RA as a conduit does not match with IMA as the athero-
sclerotic changes occur 5 times more in it when compared to
the IMA grafts-(5.3% vs 0.7%).28 Still it fares better than the
SVG in patency rates. The RVSP trial assessed the mid-term
patency of RA grafts over SVG and found it to be signifi-
cantly higher (98.3% vs 86.4% at 5 years).29 The RAPCO trial in
contrast to these studies reported a similar midterm patency
rates for RA grafts and SVG (90% vs 87%).30 Tranbaugh and
colleagues recently analyzed the long term outcomes of RA
grafting vs SVG with 14 year follow up. They found that the
SVG group had 52% higher mortality than the RA group irre-
spective of the territory grafted. Particularly, RA grafting
added survival benefit to younger men.31
RA can be harvested either using an open technique or
with the help of an endoscope. It can be used as a composite
graft or a direct aorto-coronary graft with no difference in the
long term patency. The sequential use of RA for multiple
target grafting also can be done on pump or off pump with
superior patency rates than a LIMAeSVG sequential graft.
i n d i a n h e a r t j o u r n a l 6 7 ( 2 0 1 5 ) 3 5 1e3 5 8354The major drawback of RA is its vasospastic tendency due
to a thick medial layer with tightly packed smooth cells.28 The
vasospastic tendency of RA can be counteracted with the use
of topical agents like papaverine, phenoxybenzamine and
verapamil with nitroglycerine which are commonly used in
clinical practice. Recently fasudil a rho kinase inhibitor has
been found to be useful intra-radially to relieve its spasm.32
In short, the current evidence states that SVG may
compare well with RA in the patency rates during short term
follow up, but definitely RA scores better in the long term.
Also, RA use should be planned on the right coronary system
only if there is high grade stenosis of the target vessel which
supplies a large area of viable myocardium33 and in younger
men where they yield better results.
3.1.3. Right gastroepiploic artery (RGEA)
RGEA is the least used arterial conduit among the three.
Although it has shown superior patency rates compared to
SVG in some studies, its use has never become popular.
Suzuki et al found better outcomes with RGEA use when
compared with SVG on to the RCA especially when a ske-
letonised technique of harvest was utilized.34
In contrast, DeMauro et al in a long term follow up analysis
criticized the use of RGEA on the right coronary system
quoting an increased rate of adverse events at the end of 8
years. They advocated the use of supplementary venous
grafting rather than RGEA onto the right coronary system
when BIMA grafting is done.35
The short length of RGEA generally permits its use only as
an in situ pedicled graft onto the right coronary system. SVG
when grafted is functionally a first or second branch of aorta
in contrast to the RGEA which originates as the fourth branch
of the visceral arterial tree. The resultant difference in the
flow dynamics could be the reason for the inferior patency
rates and its unpopularity.204. Intra-operative graft flow assessment
The utility of intra-operative graft flow assessment is useful in
predicting the technical perfection of the anastomosis objec-
tively. The incidence of intra-operative graft flow failure has
beenstudied and found to average about 5% for IMAand11% for
the SVG. The anastomotic problems or the limited distal flow in
the native coronaries could produce flow compromise in the
grafts.36 Although coronary angiography is considered the gold
standard for assessing the graft patency, the logistic difficulties
make its use impractical peri-operatively. Various other in-
novations namely transit time flow measurement (TTFM),
thermal angiography, sonography based modalities (Doppler
velocity measurements, epicardial colour Doppler) and intra-
operative fluorescence imaging (IFI) have come in vogue.
The earliest attempts to quantify the graft functionality
were the use of myocardial pH electrodes to assess metabol-
ically the regional perfusion.37 During the same period Mohr
et al popularized the intra-operative thermal angiography
technique for graft assessment and reported its utility.38
The most common modalities used in the current era to
this end are TTFM and IFI. The graft patency ideally should be
confirmed based on its anatomical and functional imaging.TTFM is an excellent tool to assess the functionality of the
graft. A low pulsatility index with high flow rate by TTFM
confirms graft patency. A pulsatility index of >5 usually in-
dicates graft occlusion by TTFM. But the incidence of false
negatives-grafts with poor flow and low pulsatility index
limits its use.39 Giammarco et al recently reported the utility
of a combined approach using TTFM and epicardial ultra-
sound. The addition of the high resolution epicardial ultra-
sound to TTFM was shown to eliminate the false negatives
and comprehensively assesses the graft patency both
morphologically and functionally yielding an accuracy of
100%.40
IFI angiography is a semi-quantitative tool for the assess-
ment of intra-operative graft patency. It uses laser activated
indocyanine green dye for the assessment of the grafts. Its
limitation is that it does not allow the exact flow through the
graft to be quantified and thus is only useful in assessing the
morphology of the grafts. Also, the laser beam used for the
quantification has a penetration of only 1 mm limiting its
utility in certain situations where the anastomosis is in the
depth.41 IFI delineates themorphology of grafts clearly but the
functional quantification of the graft patency is indirectly
measured based on the dye wash out delay in terms of heart
beats (HB) (15 HB-good flow, >15 HB-low flow, dye pooling in
the graft-occlusion).42
The routine use of intra-operative graft assessment pro-
vides early identification of failed grafts, buys lead time for the
surgeon to adopt corrective measures and consequently de-
creases the rates of early graft failure.5. Minimally invasive and hybrid techniques
Patients are often disillusioned by the invasiveness of on/
OPCAB and prefer to have a percutaneous procedure if the
option is available, although the phenomenon of temporal
discounting is operational-the emphasis on the short term
benefits of PCI overlooking the full range of benefits of CABG.2
The recent advances in the minimally invasive cardiac sur-
gery (MICS) with the improved retractors and modified in-
struments have made these options viable for the surgeons
and patients. The 2011 ACC/AHA guidelines predict that in the
future CABG will need to evolve into less invasive techniques
for elective coronary revascularization.43
Minimally invasive direct coronary artery bypass (MIDCAB)
avoids sternotomy and its attendant complications. Despite
the increase in post-operative pain due to the amount of chest
spreading involved in the left anterior thoracotomy approach,
it has added benefits like earlier discharge, cosmetic superi-
ority, improved patient satisfaction and better quality of life.
Holzhey et al reported long term follow up data of MIDCAB
procedures which were mostly single anastomoses to the
anterior left coronary system in a low Euroscore cohort. They
reported survival rates of 88.3% and 76.6% at 5 and 10 years of
follow up respectively.44
AsMIDCAB offers a limited exposure ofmostly the anterior
surface of the heart its utility is mostly restricted to grafting
LIMA- LAD. But with the advanced minimally invasive tech-
niques there are centers performing multi-vessel grafting
even in the lateral and inferior surfaces of the heart employing
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MIDCABS are still awaited.
Recently BIMA grafting employing MIDCAB techniques
have been proposed. Nambiar et al had proposed a technique
of harvesting BIMA via a left anterior thoracotomywithout the
use of thoracoscope or robot under direct vision. TACR was
achieved by fashioning a LIMAeRIMA Y-composite conduit.46
The feasibility of combining BIMA use into MIDCAB pro-
cedures thus achieving MAG can give an added edge to the
coronary surgeon.
Totally endoscopic coronary artery bypass (TECAB) and
Robot assisted CABG are other lesser invasive approaches.
Though the initial results of TECAB were discouraging, the
recent reports from highly experienced centers show com-
parable mortality rates of 1e2% as compared with the con-
ventional procedures.47 The high degree of technical expertise
involved, the infrastructure and equipment costs coupled
with the steep learning curve limit the widespread applica-
bility of these techniques.
Hybrid coronary revascularization (HCR) is yet another
avenue which facilitates the co-operation between cardiolo-
gists and cardiac surgeons. There is strong evidence sup-
porting the survival benefit and symptom relief provided by a
LIMA- LAD anastomosis in the literature.4 Also there are re-
ports claiming the superiority of drug eluting stents (DES) over
the SVG at least in the short term when used for treating non-
LAD lesions.48
The basic indications for HCR is a suitable coronary anat-
omy where we can blend the two modalities (PCI and CABG)
conferring the benefit of a LIMAeLAD anastomosis to the
critically stenosed LAD, performed through a minimally
invasive approach and the advantages of a percutaneous DES
to the significant non-LAD targets. Short term results of this
approach have been satisfactory with survival rates reported
with HCR similar to those of traditional CABG. The relative
contraindications for HCR include poor LAD target, hemody-
namic instability, redo surgery, pulmonary disease with
contraindication to single-lung ventilation, morbid obesity
and non-LAD disease not amenable to PCI.49 Randomized
trials to confirm the results from the available retrospective
data on HCR are overdue as it presents a durable and less
invasive treatment option for multi-vessel CAD.
In the Indian context, the number of PCI done in acute coro-
nary syndrome (ACS) is rapidly increasing. Patients having
culprit vessel PCI to non-LAD targets may have a longer term
benefit if their LAD lesions are later treated with a LIMAeLAD
anastomosis using a left thoracotomy minimally invasive
approach.Thecost implicationsofHCRmaystill breakevenwith
multi-vessel PCI considering the repeat revascularizations,2,3,11
the accompanying hospitalizations and follow up visits associ-
ated with PCI. This might make HCR an economically viable
option in India and other developing countries.6. Endoscopic and no touch techniques of
vein harvesting
Although endoscopic vein harvesting [EVH] has the purported
advantages of early recovery, lesser post-operative pain and
reduced incidence of harvest site complications, the data fromPREVENT IV trials reported inferior patency rates when this
technique was employed with an associated increase in
mortality.50
A large observational study comparing EVH vs open venous
harvest technique recently has reported comparable out-
comes with regard to mortality rates, incidence of major
adverse cardiac or cerebrovascular events and revasculariza-
tion rates. The harvest site complications were reported to be
lower in the EVH group. This has resulted in a paradigm shift
for reconsideration of the technique.51
The concept of no touch vein harvest technique i.e. har-
vesting the saphenous vein with an intact periadventitial
tissue was introduced on the premise that it produces lesser
intimal damage. Recent reports suggest that the adherence to
the no touch technique of vein harvest resulted in better graft
patency rates angiographically.52
The value of these observations lies in the utility of SVG in
supplementary grafting-i.e. the deployment of the arterial
grafts on the left coronary systemwhere they yield better long
term results, can leave right coronary system potentially
amenable for SVG use. SVG has been reported to have similar
patency rates when compared with RA grafts when used on
the right coronary branches without high grade stenosis at 8
years follow up.53
These techniques of SVG harvest along with the concept of
supplementary venous graftingmay revive the interest in SVG
use although, further trials may reveal their true value.7. Heart team approach
This concept has proven its viability with the advent of Trans-
aortic valve replacement [TAVR]. The efficiency of this team
approach demonstrates that in the management of CAD
which demandsmultipronged treatment options a synergistic
effect as evidenced in HCR may be useful. The multidisci-
plinary heart team should comprise of clinical/interventional
cardiologist, cardiovascular surgeons, anesthetists and the
primary care physicians interacting cohesively to tackle the
decision making dilemma and provide comprehensive care in
CAD. The importance of the Heart Team (HT) Approach has
been stressed in SYNTAX trial and it should be integrated into
all coronary care facilities.2 A proposed algorithm for man-
agement of CAD with the “HT approach” in Indian scenario is
shown in Fig. 1.
Anatomical SYNTAX score has become amajor tool for the
HT in assessing the risk for MACCE and can guide manage-
ment decisions. However the burden of comorbidities like age,
COPD, peripheral vascular disease, DM, smoking and poor
general health do play a significant role in the decisionmaking
on the surgical candidacy. The advent of risk scoring systems
like SYNTAX II and functional SYNTAX afford to devise amore
individualized treatment plan and have furthered the risk
assessment ability of the HT by combining both the anatom-
ical, functional and comorbid factors for predicting the risk of
intervention. Although SYNTAX II does not take into account
DM as a predictor of peri-operative risk, it is an important tool
in assisting the choice of intervention. Moreover SYNTAX II
has been validated in the DELTA registry involving Asian
population which can augment its applicability in the Indian
Fig. 1 e Proposed algorithm for management of CAD utilizing “the Heart team approach” in Indian scenario. PCI-
percutaneous coronary intervention, cCABG-conventional/on pump CABG, OPCAB-off pump CABG, MIDCAB-minimally
invasive direct coronary artery bypass, FFR-fractional flow reserve, DM-diabetes mellitus. PCI*-if not diabetic.
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lation of SYNTAX score (culprit vessel scoring) i.e. the func-
tional SYNTAX has been proposed after the FAME trial, the
feasibility of routinely incorporating it into clinical practice in
a developing country may be limited by cost constraints.558. Conclusion
The adoptability of the surgical strategies outlined here vary
between surgeons, centers and target populations. However
their utility in ensuring better patient outcomes has been
reasonably well established. The weak spots in the practice of
CABG could potentially be rectified by the adoption of these
strategies although they often involve unlearning and
relearning. The evolution of catheter based techniques in the
treatment of CAD should be integrated with enthusiasm by
the surgical community as it would provide the necessary
impetus in the proliferation of HCR and other minimally
invasive techniques with proportionally better patient out-
comes. The practice of cardiovascular surgery and cardiology
pertaining to the treatment of CAD should thus be competitive
at all levels at the same time mutually complementary. To
conclude-“If you want to be incrementally better: Be
competitive. If you want to be exponentially better: Be co-
operative.”Conflicts of interest
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